Error: Could not add to watchlist. X

Gilead Pharmasset LLC

+ Watchlist
VRUS:US
Acquired
VRUS:US was acquired by GILD:US
USD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.06
Market Cap (USD)
-
Shares Outstanding (m)
75.657
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Gilead Pharmasset LLC is a pharmaceutical company. The Company develops oral therapeutics for the human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV).
ADDRESS
303-A College Road East
Princeton, NJ 08540
United States
PHONE
1-609-613-4100
  • Herbert J Conrad
    Chairman
  • P Schaefer Price
    President/CEO
  • Kurt W Leutzinger
    Chief Financial Officer
  • Michael J Otto
    Chief Scientific Officer
Show More